Chronic Disease  >>  dilmapimod (SB-681323)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dilmapimod (SB-681323) / GSK
NCT00380133: Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients

Completed
1
20
Europe
SB681323, Prednisolone, Placebo
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
04/06
04/06
NCT00564746: To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males

Completed
1
4
Europe
A single 10 milligram (50 microcurie) oral dose of [14C]SB-681323
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
10/07
10/07

Download Options